SCHEMBL6713264

SCHEMBL6713264

CC(=O)Oc1ccc2c(C(=O)Nc3ccc(Br)cc3-c3nnn[nH]3)noc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 4/20 0.39
HIF1A Q16665 8/20 0.35
POLB P06746 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
GAA P10253 3/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
GLA P06280 2/20 0.32
HPGD P15428 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MGAM O43451 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710496 0.91 GPR35 (0.46) GPR35HIF1APOLBMEN1KMT2A
SCHEMBL6710363 0.90 HIF1A (0.39) HIF1APOLBMEN1KMT2ALMNA
SCHEMBL6710147 0.87 TP53 (0.34) HIF1APOLBMEN1KMT2ARXFP1
SCHEMBL6710174 0.86 HIF1A (0.36) GPR35HIF1AMEN1KMT2ANPSR1
SCHEMBL6711803 0.85 HIF1A (0.38) GPR35HIF1APOLBMEN1KMT2A
SCHEMBL6711782 0.85 HIF1A (0.41) GPR35HIF1AMEN1KMT2ANPSR1
SCHEMBL6712127 0.85 HIF1A (0.35) GPR35HIF1AMEN1KMT2ANPSR1
SCHEMBL6709979 0.84 MAOB (0.35) GPR35HIF1AMEN1KMT2ANPSR1
SCHEMBL6709047 0.84 SMPD1 (0.37) GPR35HIF1ANPC1RAB9AGAA
SCHEMBL6708059 0.84 HIF1A (0.49) HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GPR35 2928/4885HIF1A 296/4885POLB 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.